BPMC - Blueprint Medicines Corp Stock Price, Fair Value and News

BPMC is the stock ticker symbol of Blueprint Medicines Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jul 18 2025, market cap of Blueprint Medicines Corp is 8.36 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check BPMC's fair value in chart for subscribers.

The fair value guage provides a quick view whether BPMC is over valued or under valued. Whether Blueprint Medicines Corp is cheap or expensive depends on the assumptions which impact Blueprint Medicines Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BPMC.

As of Fri Jul 18 2025, BPMC's PE ratio (Price to Earnings) is -53.69 and Price to Sales (PS) ratio is 14.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BPMC PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Blueprint Medicines Corp has provided 0.154 (multiply by 100 for percentage) rate of return.